Literature DB >> 3096672

Improved high-affinity monoclonal antibody to iododeoxyuridine.

M Vanderlaan, B Watkins, C Thomas, F Dolbeare, L Stanker.   

Abstract

Three monoclonal antibodies (Mabs), IU-1, IU-4, and B-44 were evaluated in enzyme immunoassays (ELISA) and by flow cytometry for their abilities to recognize bromodeoxyuridine (BrdUrd)- and iododeoxyuridine (IdUrd)-substituted DNA's, nucleotides, and nucleosides. IU-4 is a new Mab, derived from mice immunized with 5-iodo-2'-deoxyuridine-5'-monophosphate (IdUMP) conjugated (IdUMP) conjugated through the phosphate group to albumin. This immunogen was selected to resemble IdUMP in DNA. In competition ELISA assays, IU-4 prefers IdUrd to BrdUrd and prefers halogenated nucleotides over the corresponding nucleosides. In both ELISA and flow analysis, IU-4 recognizes IdUrd in DNA at substitution frequencies at least as low as one IdUrd one per 1,000 normal bases. The high affinity of IU-4 for IdUrd-DNA contrasts with IU-1 and B-44, which show a strong binding dependency on the frequency of base substitution and require DNA that is essentially fully substituted with BrdUrd for binding in both flow and ELISA assays. The high affinity of IU-4 for IdUrd in DNA and its independence of IdUrd residue spacing make it a superior reagent for the quantitative labeling of halogenated thymidine analogues in whole cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096672     DOI: 10.1002/cyto.990070602

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication.

Authors:  J A Aten; P J Bakker; J Stap; G A Boschman; C H Veenhof
Journal:  Histochem J       Date:  1992-05

2.  Flow cytometric analysis of experimental parameters for the immunofluorescent labeling of BrdUrd in various tumour cell lines.

Authors:  P J Bakker; J A Aten; C J Tukker; G W Barendsen; C H Veenhof
Journal:  Histochemistry       Date:  1989

3.  DNA denaturation for ultrastructural banding and the mechanism underlying the fluorochrome-photolysis-Giemsa technique studied with anti-5-bromodeoxyuridine antibodies.

Authors:  R Drouin; P E Messier; C L Richer
Journal:  Chromosoma       Date:  1989-09       Impact factor: 4.316

4.  Response of human HT-29 colorectal tumor cells to extended exposure to bromodeoxyuridine.

Authors:  J Maybaum; M S Hafner; E C Burton; P L Stetson; W D Ensminger; C E Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Variability in the proliferative potential of human gliomas.

Authors:  T Hoshino; T Nagashima; K G Cho; R L Davis; J Donegan; M Slusarz; C B Wilson
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

6.  Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Authors:  P P Brons; C Haanen; J B Boezeman; P Muus; R S Holdrinet; A H Pennings; H M Wessels; T de Witte
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

7.  The antibodies against 5-bromo-2'-deoxyuridine specifically recognize trifluridine incorporated into DNA.

Authors:  Hiroyuki Kitao; Yosuke Morodomi; Shinichiro Niimi; Mamoru Kiniwa; Kazuhiko Shigeno; Kazuaki Matsuoka; Yuki Kataoka; Makoto Iimori; Eriko Tokunaga; Hiroshi Saeki; Eiji Oki; Yoshihiko Maehara
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.